Multiple Sclerosis - National Association of Disability Examiners
... • Inflammatory auto-immune disease affecting the fatty myelin sheaths of the brain/spinal cord axons • Demyelination and remyelination • Scarring – Sclerosis (plaques/lesions) • Loss of conduction – electrical signal • Genetic, environmental and infectious etiologies have been suggested • Progressi ...
... • Inflammatory auto-immune disease affecting the fatty myelin sheaths of the brain/spinal cord axons • Demyelination and remyelination • Scarring – Sclerosis (plaques/lesions) • Loss of conduction – electrical signal • Genetic, environmental and infectious etiologies have been suggested • Progressi ...
Hand foot syndrome
... What are the signs and symptoms? Hand foot syndrome may occur days to weeks after commencing treatment with certain chemotherapy drugs. It most commonly develops after six weeks of treatment. The symptoms usually resolve within two weeks if the drug causing the effect is stopped. Hand foot syndrome ...
... What are the signs and symptoms? Hand foot syndrome may occur days to weeks after commencing treatment with certain chemotherapy drugs. It most commonly develops after six weeks of treatment. The symptoms usually resolve within two weeks if the drug causing the effect is stopped. Hand foot syndrome ...
73 Post-polio syndrome and amyotrophic lateral sclerosis
... u Often fear, anxiety, rarely depression ...
... u Often fear, anxiety, rarely depression ...
Gilbert syndrom
... Gilbert’s Syndrome is an inherited form of unconjugated hyperbilirubinaemia resulting in mild jaundice occurring in the absence of haemolysis or other underlying liver disease. Typically, total serum bilirubin concentration is between 20 and 50 μmol/L and may be noticeable within the sclera, skin an ...
... Gilbert’s Syndrome is an inherited form of unconjugated hyperbilirubinaemia resulting in mild jaundice occurring in the absence of haemolysis or other underlying liver disease. Typically, total serum bilirubin concentration is between 20 and 50 μmol/L and may be noticeable within the sclera, skin an ...
A rare case of Mounier-Kuhn syndrome with bronchial asthma
... trachea and central bronchi with an abrupt transition to a normal caliber of the peripheral airways.[4] For an adult, an increased diameter of the trachea, the right and the left main bronchus that exceeds 3.0, 2.4, and 2.3 cm, respectively, on a standard chest radiograph or bronchogram is diagnosti ...
... trachea and central bronchi with an abrupt transition to a normal caliber of the peripheral airways.[4] For an adult, an increased diameter of the trachea, the right and the left main bronchus that exceeds 3.0, 2.4, and 2.3 cm, respectively, on a standard chest radiograph or bronchogram is diagnosti ...
Horner Syndrome at a Glance
... brainstem and cervical spinal cord to the level of T1-T3 spinal segments. Preganglionic (Second Order) Neurons Axons of preganglionic neurons, which arise in the T1-T3 spinal region, leave the spinal cord through the ventral roots and pass through the cranial thorax and neck as part of the vagosympa ...
... brainstem and cervical spinal cord to the level of T1-T3 spinal segments. Preganglionic (Second Order) Neurons Axons of preganglionic neurons, which arise in the T1-T3 spinal region, leave the spinal cord through the ventral roots and pass through the cranial thorax and neck as part of the vagosympa ...
401-Chronic-Neuro2
... – Heaviness or weakness in extremities – Numbness or tingling in extremities ...
... – Heaviness or weakness in extremities – Numbness or tingling in extremities ...
Q 1 Define nephritoc syndrome. Enumerate its common causes and
... 2 treatment of underlying diseasesMinimal change disease is usually steroid responsive. It is treated by prednisolone 40 mg/day for 4 weeks and then 35 mg/day for alternate days for another 4 weeks . other drugs likecyclophosphamide, cyclosporine, mycophenolate mofetil can be given in unresponsive c ...
... 2 treatment of underlying diseasesMinimal change disease is usually steroid responsive. It is treated by prednisolone 40 mg/day for 4 weeks and then 35 mg/day for alternate days for another 4 weeks . other drugs likecyclophosphamide, cyclosporine, mycophenolate mofetil can be given in unresponsive c ...
Chapter 15 Genetic Disorder Chart
... 1 in 3,500 males in US Rarely live past early 20’s Disorder due to absence of X-linked gene for a key muscle protein called dystrophin Disease is characterized by progressive weakening of muscles and loss of coordination Absence of one or more clotting factors Blood clots form slowly and ...
... 1 in 3,500 males in US Rarely live past early 20’s Disorder due to absence of X-linked gene for a key muscle protein called dystrophin Disease is characterized by progressive weakening of muscles and loss of coordination Absence of one or more clotting factors Blood clots form slowly and ...
A-1 POTASSIUM CHANNEL ANTIBODY
... Voltage-gated potassium channel (VGKC) antibodies were first described in acquired neuromyotonia whish is a syndrome of spontaneous and continuous muscle fiber contraction resulting from hyperexcitability of motor nerves, and may be part of a spectrum of diseases that includes cramp fasciculation sy ...
... Voltage-gated potassium channel (VGKC) antibodies were first described in acquired neuromyotonia whish is a syndrome of spontaneous and continuous muscle fiber contraction resulting from hyperexcitability of motor nerves, and may be part of a spectrum of diseases that includes cramp fasciculation sy ...
Case for LU#4. Mysterious paralysis
... paralysis at Beijing Hospital. In the reports, pathologists noticed that the patients had normal myelin but damaged axons. In some cases, the axon had been completely destroyed, leaving only a hollow shell of myelin. Q#5. Do the results of Dr. McKhann’s investigation and autopsy suggest that the Chi ...
... paralysis at Beijing Hospital. In the reports, pathologists noticed that the patients had normal myelin but damaged axons. In some cases, the axon had been completely destroyed, leaving only a hollow shell of myelin. Q#5. Do the results of Dr. McKhann’s investigation and autopsy suggest that the Chi ...
Mutations and Genetic Diseases
... Down syndrome symptoms vary from person to person and can range from mild to severe. However, children with Down syndrome have a widely recognized appearance. ...
... Down syndrome symptoms vary from person to person and can range from mild to severe. However, children with Down syndrome have a widely recognized appearance. ...
Guillain-Barre Syndrome
... • Various studies since 1985 • Time on ventilator reduced by ½ • Full strength regained at 1 year: Exchange ...
... • Various studies since 1985 • Time on ventilator reduced by ½ • Full strength regained at 1 year: Exchange ...
Guillan-Barre Syndrome
... disorder progresses, muscle weakness can evolve into paralysis. Extreme cases cause difficulty in breathing and require hospitalization. One in ten cases result in a permanent disability. Since there is no cure, only supportive therapy can be provided. Even ...
... disorder progresses, muscle weakness can evolve into paralysis. Extreme cases cause difficulty in breathing and require hospitalization. One in ten cases result in a permanent disability. Since there is no cure, only supportive therapy can be provided. Even ...
Neuromuscular weakness and paralysis
... Muscles of our body are controlled via motor nerves that are stimulating their contraction. If this nervous transmission is interrupted by nerve or muscle disease then weakness of the involved muscles will result. The two common causes of severe neuromuscular weakness are myasthenia gravis and the G ...
... Muscles of our body are controlled via motor nerves that are stimulating their contraction. If this nervous transmission is interrupted by nerve or muscle disease then weakness of the involved muscles will result. The two common causes of severe neuromuscular weakness are myasthenia gravis and the G ...
Guillain-Barré syndrome
... First symptoms are usually tingling and numbness in the fingers and toes with progressive weakness in the arms and legs during the next few days. In the mildest of cases, the weakness may cause only moderate difficulty in walking. In more serious cases, the weakness progresses and leads to complete ...
... First symptoms are usually tingling and numbness in the fingers and toes with progressive weakness in the arms and legs during the next few days. In the mildest of cases, the weakness may cause only moderate difficulty in walking. In more serious cases, the weakness progresses and leads to complete ...
Guillain–Barré syndrome
Guillain–Barré syndrome (GBS, French pronunciation: [ɡiˈlɛ̃ baˈʁe], English pronunciation: /ɡiːˈjænbɑrˈeɪ/), also known as Guillain–Barré–Strohl syndrome or Landry's paralysis, is a rapid-onset muscle weakness as a result of damage to the peripheral nervous system. Many experience changes in sensation or develop pain, followed by muscle weakness beginning in the feet and hands. The symptoms develop over half a day to two weeks. During the acute phase, the disorder can be life-threatening with about a quarter developing weakness of the breathing muscles and requiring mechanical ventilation. Some are affected by changes in the function of the autonomic nervous system, which can lead to dangerous abnormalities in heart rate and blood pressure.This autoimmune disease is caused by the body's immune system mistakenly attacking the peripheral nerves and damaging their myelin insulation. Sometimes this immune dysfunction is triggered by an infection. The diagnosis is usually made on based on the signs and symptoms, through the exclusion of alternative causes, and supported by tests such as nerve conduction studies and examination of the cerebrospinal fluid. Various classifications exist, depending on the areas of weakness, results of nerve conduction studies, and the presence of antiganglioside antibodies. It is classified as an acute polyneuropathy.In those with severe weakness, prompt treatment with intravenous immunoglobulins or plasmapheresis, together with supportive care, will lead to good recovery in the majority. Some may experience ongoing difficulty with walking, painful symptoms, and some require long-term breathing support. Guillain–Barré syndrome is rare, at one to two cases per 100,000 people every year. The syndrome is named after the French neurologists Georges Guillain and Jean Alexandre Barré, who described it with André Strohl in 1916.